ClinicalTrials.gg
Sign In

Keratoconjunctivitis Sicca clinical trials

The registry lists 85 studies for Keratoconjunctivitis Sicca across more than 10 countries. 1 are recruiting or about to start. 63 of them are mainly about Keratoconjunctivitis Sicca (how this is decided). Per ClinicalTrials.gov, last updated 2026-09-18.

Get an email when these change. Save the Keratoconjunctivitis Sicca studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
74
Withdrawn
5
Status unknown
3
Terminated
1
Active, not recruiting
1
Not yet recruiting
1

Phase

Phase 2
26
Phase 3
23
Phase 4
11
Phase 1
5

Where

United States
56
Spain
4
Israel
3
France
3
Taiwan
2
Germany
2

Who runs them

Oculeve, Inc. (4) · Allergan (4) · Sun Pharmaceutical Industries Limited (4) · Kala Pharmaceuticals, Inc. (3) · Rigel Pharmaceuticals (3) · Mimetogen Pharmaceuticals USA, Inc. (3) · Otsuka Pharmaceutical Development & Commercialization, Inc. (2) · Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA (2)

What is being tested here

Drugs under test in Keratoconjunctivitis Sicca studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Lubricant Eye Drops102
Fulipiftide101
Cyclosporine016
Loteprednol Etabonate025
Rebamipide024
Tavilermide033
Lifitegrast013
Cyclosporine Ophthalmic Emulsion003
INV-102002
Tivanisiran022

Drug classes tested here Calcineurin inhibitors 7 · Corticosteroids 3

Coming up

0phase 3 studies under way
1study finishes main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The study

Who these studies take

No Keratoconjunctivitis Sicca study is recruiting now.

Across all 85 studies, recruiting or not: 12% stop at 75 or younger and 7% at 65; 6% take children; 4% are for women only and 0% for men only; 21% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Keratoconjunctivitis Sicca studies take

Of 12 phase 3 interventional studies under Keratoconjunctivitis Sicca, half reached primary completion within 14 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 314 mo7–18 · 12 studies——
Interventional, no phase7 mo2–17 · 10 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 50 of 85. Browse all 85 → or search them.